How big is the hydrocortisone market today, and what are its future growth expectations?
The hydrocortisone market size has grown strongly in recent years. It will grow from $1.52 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising skin disorder prevalence, an aging population, increased awareness and accessibility, pharmaceutical industry growth, and emerging market expansion.
The hydrocortisone market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements, OTC demand surge, research and demand investments, growing disposable income, expanded distribution channels. Major trends in the forecast period include natural ingredient focus, combination therapies, personalized treatments, hydrocortisone-infused products, and sustainability emphasis.
Get Your Free Sample of The Global Hydrocortisone Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16446&type=smp
Which industry factors have accelerated the hydrocortisone market’s expansion?
The increasing prevalence of inflammatory and autoimmune diseases is expected to propel the growth of the hydrocortisone market going forward. Inflammatory and autoimmune diseases are conditions where the immune system mistakenly attacks the body’s tissues, causing chronic inflammation and tissue damage. The rising adoption of treatments for inflammatory and autoimmune diseases is due to the increasing prevalence of these conditions and advancements in medical therapies. Hydrocortisone is used in inflammatory and autoimmune diseases such as severe asthma exacerbations to reduce airway inflammation and improve breathing rapidly. It is typically administered intravenously in emergencies. For instance, in May 2024, according to the data published by the National Center for Health Statistics (NCHS), a U.S.-based health statistics agency, the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Additionally, asthma episodes in the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, the increasing prevalence of inflammatory and autoimmune diseases will drive the growth of the hydrocortisone market.
What are the primary segments of the hydrocortisone market?
The hydrocortisone market covered in this report is segmented –
1) By Type: Cream, Injection, Tablet
2) By Route Of Administration: Parenteral, Oral, Topical
3) By Application: Adrenocortical Dysfunction, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma And Chronic Obstructive Pulmonary Disease, Other Application
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Cream: Topical Hydrocortisone Cream (0.5%, 1%, 2.5%), Hydrocortisone Ointment
2) By Injection: Hydrocortisone Sodium Succinate Injection, Hydrocortisone Acetate Injection
3) By Tablet: Oral Hydrocortisone Tablets (5mg, 10mg, 20mg), Extended-Release Hydrocortisone Tablets
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/hydrocortisone-global-market-report
Which firms are leading the hydrocortisone market?
Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc, AbbVie Inc., Bayer AG, Novartis AG, The Dow Chemical Company, GlaxoSmithKline plc (GSK), Viatris Inc., Solvay SA, Teva Pharmaceutical Industries Ltd., Alcon Inc, Sandoz International GmbH, Valeant Pharmaceuticals International Inc, Fresenius Kabi AG, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Ivax Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Impax Laboratories LLC, Akorn Incorporated, Taro Pharmaceutical Industries Ltd, Lannett Company Inc, Salix Pharmaceuticals Inc
Which market trends are set to define the future of the hydrocortisone market?
Major companies operating in the hydrocortisone market are focusing on combination therapies, such as lotions combined with butyrate active ingredients, to enhance treatment efficacy and broaden their product portfolios. Hydrocortisone combined with butyrate lotion offers a potential synergy in managing skin conditions by leveraging hydrocortisone’s anti-inflammatory properties alongside butyrate’s immunomodulatory effects and potential for improving skin barrier function. For instance, in November 2023, J. Molner AS., an Estonian-based pharmaceutical company, launched Hydrocortisone Butyrate Lotion, 0.1%, in the United States, marking a key milestone in its strategy to build a commercial platform for its pharmaceutical products in global markets. The newly available lotion is designed to treat inflammatory skin conditions, reflecting Molner’s commitment to expanding its international market presence.
Which geographic trends are shaping the hydrocortisone market, and which region has the highest market share?
North America was the largest region in the hydrocortisone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Hydrocortisone Market Report 2025 Offer?
The hydrocortisone market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hydrocortisone is a corticosteroid hormone naturally produced by the adrenal glands and vital for regulating metabolism and immune responses. It is synthesized and used to treat various conditions, primarily as an anti-inflammatory agent, often applied topically to alleviate skin inflammation and itching.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16446
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
